Elevated Plasma D-Dimer Concentrations in Adults after an Outpatient-Treated COVID-19 Infection

Christa Meisinger1, Inge Kirchberger1,2, Tobias D Warm3

  • 1Epidemiology, Faculty of Medicine, University Hospital of Augsburg, University of Augsburg, 86156 Augsburg, Germany.

Viruses
|November 11, 2022
PubMed

Insights

Elevated D-dimer levels in outpatients after COVID-19 are linked to inflammation markers, not symptoms. This finding suggests prolonged D-dimer elevation may indicate ongoing inflammatory processes post-infection.

Area of Science:

  • Internal Medicine
  • Infectious Diseases
  • Hematology

Background:

  • Elevated D-dimer is common in hospitalized COVID-19 patients, correlating with poor outcomes.
  • The significance of D-dimer levels in outpatients after COVID-19 remains unclear.
  • Understanding post-COVID-19 D-dimer trends is crucial for assessing long-term health implications.

Purpose of the Study:

  • To evaluate D-dimer levels in individuals treated as outpatients after COVID-19.
  • To investigate the association between D-dimer levels and clinical parameters, including inflammation biomarkers.
  • To determine if D-dimer elevation post-COVID-19 correlates with acute or persistent symptoms.

Main Methods:

  • Cross-sectional study of 411 outpatients with a history of COVID-19.
  • Plasma D-dimer levels measured using a particle-enhanced immunoturbidimetric assay.
  • Multivariable logistic regression analysis to identify associations with clinical and inflammatory markers.

Main Results:

  • 15% of participants had elevated D-dimer levels (≥500 µg/L).
  • Elevated D-dimer was associated with older age and a history of cardiovascular disease, hypertension, venous thromboembolism, and chronic venous insufficiency.
  • C-reactive protein (CRP) levels and white blood cell count were significantly associated with elevated D-dimers, while symptoms were not.

Conclusions:

  • Elevated D-dimer levels months after outpatient COVID-19 appear linked to inflammation markers, not current symptoms.
  • Further research is necessary to elucidate the pathophysiology and long-term consequences of persistent D-dimer elevation post-COVID-19.
  • Findings suggest D-dimer may serve as a marker for subclinical inflammatory processes in some post-COVID-19 patients.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
26
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
31
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
27
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
26
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
33